Literature DB >> 21798636

Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients.

L Genton1, V Viatte, J-P Janssens, A-C Héritier, C Pichard.   

Abstract

Amyotrophic lateral sclerosis (ALS) alters nutritional state, energy intake and energy expenditure. This article aims at reviewing present knowledge on these topics in order to determine energy requirements for maintaining a neutral energy balance in ALS patients. Maintaining a neutral energy balance prevents malnutrition and its complications and may improve physical functioning, quality of life and survival. Prevalence of malnutrition varies between 16 and 55% in ALS patients. Energy intakes are below recommended dietary allowances in 70% of ALS patients at least. These elements suggest a chronic negative energy balance with an imbalance between requirements and intakes. While insufficient intakes can be compensated with nutritional support, the energy requirements are unclear. Studies generally report hypermetabolism in ALS patients. Estimation of total energy expenditure and as a corollary energy needs, necessitates taking into account this hypermetabolism, physical activity and possibly mechanical ventilation. The review suggests a flow chart for optimal nutritional follow-up in clinics. Further studies are required to assess whether optimal nutritional follow-up improves outcome.
Copyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21798636     DOI: 10.1016/j.clnu.2011.06.004

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  19 in total

1.  Survey of current enteral nutrition practices in treatment of amyotrophic lateral sclerosis.

Authors:  May Zhang; Jane Hubbard; Stacy A Rudnicki; Carolyn S Johansen; Kate Dalton; Terry Heiman-Patterson; Dalles A Forshew; Anne-Marie Wills
Journal:  ESPEN J       Date:  2013-02-01

Review 2.  Supportive and symptomatic management of amyotrophic lateral sclerosis.

Authors:  Esther V Hobson; Christopher J McDermott
Journal:  Nat Rev Neurol       Date:  2016-08-12       Impact factor: 42.937

3.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz
Journal:  Lancet       Date:  2014-02-28       Impact factor: 79.321

4.  Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling.

Authors:  Gopalakrishnan Natarajan; Curtis Perriotte-Olson; Fatema Bhinderwala; Robert Powers; Cyrus V Desouza; Geoffrey A Talmon; Jiang Yuhang; Matthew C Zimmerman; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Transl Res       Date:  2017-08-15       Impact factor: 7.012

5.  High-fat and ketogenic diets in amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Anne-Marie Wills
Journal:  J Child Neurol       Date:  2013-05-10       Impact factor: 1.987

6.  Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Sagit Golko-Perez; Silvia Mandel; Tamar Amit; Lana Kupershmidt; Moussa B H Youdim; Orly Weinreb
Journal:  Neurotox Res       Date:  2015-11-18       Impact factor: 3.911

7.  Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease.

Authors:  Wei Zhao; Merina Varghese; Prashant Vempati; Anastasiya Dzhun; Alice Cheng; Jun Wang; Dale Lange; Amanda Bilski; Irene Faravelli; Giulio Maria Pasinetti
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival.

Authors:  Rup Tandan; Evan A Levy; Diantha B Howard; John Hiser; Nathan Kokinda; Swatee Dey; Edward J Kasarskis
Journal:  Am J Clin Nutr       Date:  2022-05-01       Impact factor: 8.472

9.  Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study.

Authors: 
Journal:  Lancet Neurol       Date:  2015-05-28       Impact factor: 44.182

Review 10.  Evaluation of Dysphagia in Motor Neuron Disease. Review of Available Diagnostic Tools and New Perspectives.

Authors:  Elisabet Romero-Gangonells; M Núria Virgili-Casas; Raúl Dominguez-Rubio; Mònica Povedano; Núria Pérez-Saborit; Nahum Calvo-Malvar; Maria A Barceló
Journal:  Dysphagia       Date:  2020-08-14       Impact factor: 3.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.